nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alzheimer's Association Update
|
|
|
2013 |
9 |
3 |
p. 360-361 2 p. |
artikel |
2 |
Alzheimer's disease pathology does not mediate the association between depressive symptoms and subsequent cognitive decline
|
Royall, Donald R. |
|
2013 |
9 |
3 |
p. 318-325 8 p. |
artikel |
3 |
Amyloid positron emission tomography with 18F-flutemetamol and structural magnetic resonance imaging in the classification of mild cognitive impairment and Alzheimer’s disease
|
Duara, Ranjan |
|
2013 |
9 |
3 |
p. 295-301 7 p. |
artikel |
4 |
A prediction model to calculate probability of Alzheimer’s disease using cerebrospinal fluid biomarkers
|
Spies, Petra E. |
|
2013 |
9 |
3 |
p. 262-268 7 p. |
artikel |
5 |
Benefits of combined cholinesterase inhibitor and memantine treatment in moderate–severe Alzheimer's disease
|
Gauthier, Serge |
|
2013 |
9 |
3 |
p. 326-331 6 p. |
artikel |
6 |
Cognitive and functional resilience despite molecular evidence of Alzheimer’s disease pathology
|
Negash, Selam |
|
2013 |
9 |
3 |
p. e89-e95 nvt p. |
artikel |
7 |
Cognitive correlates of cerebrospinal fluid biomarkers in frontotemporal dementia
|
Koedam, Esther L.G.E. |
|
2013 |
9 |
3 |
p. 269-275 7 p. |
artikel |
8 |
Contents
|
|
|
2013 |
9 |
3 |
p. A1-A2 nvt p. |
artikel |
9 |
CSF biomarker variability in the Alzheimer's Association quality control program
|
Mattsson, Niklas |
|
2013 |
9 |
3 |
p. 251-261 11 p. |
artikel |
10 |
Discriminatory and predictive capabilities of enzyme-linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer’s disease study
|
Jongbloed, Wesley |
|
2013 |
9 |
3 |
p. 276-283 8 p. |
artikel |
11 |
Editorial Board
|
|
|
2013 |
9 |
3 |
p. A3- 1 p. |
artikel |
12 |
Effectiveness of antidementia drugs in delaying Alzheimer's disease progression
|
Rountree, Susan D. |
|
2013 |
9 |
3 |
p. 338-345 8 p. |
artikel |
13 |
Homocysteine, progression of ventricular enlargement, and cognitive decline: The Second Manifestations of ARTerial disease-Magnetic Resonance study
|
Jochemsen, Hadassa M. |
|
2013 |
9 |
3 |
p. 302-309 8 p. |
artikel |
14 |
Medical and Scientific Advisory Council
|
|
|
2013 |
9 |
3 |
p. A4- 1 p. |
artikel |
15 |
Mild cognitive impairment in a community sample: The Sydney Memory and Ageing Study
|
Brodaty, Henry |
|
2013 |
9 |
3 |
p. 310-317.e1 2861 p. |
artikel |
16 |
Phenotypic regional functional imaging patterns during memory encoding in mild cognitive impairment and Alzheimer's disease
|
Browndyke, Jeffrey N. |
|
2013 |
9 |
3 |
p. 284-294 11 p. |
artikel |
17 |
Predictors and outcomes for caregivers of people with mild cognitive impairment: A systematic literature review
|
Seeher, Katrin |
|
2013 |
9 |
3 |
p. 346-355 10 p. |
artikel |
18 |
Risk disclosure and preclinical Alzheimer’s disease clinical trial enrollment
|
Grill, Joshua D. |
|
2013 |
9 |
3 |
p. 356-359.e1 3235 p. |
artikel |
19 |
Standardization of analysis sets for reporting results from ADNI MRI data
|
Wyman, Bradley T. |
|
2013 |
9 |
3 |
p. 332-337 6 p. |
artikel |
20 |
Subscriber information
|
|
|
2013 |
9 |
3 |
p. A5- 1 p. |
artikel |
21 |
Systematic review of the body of evidence for the use of biomarkers in the diagnosis of dementia
|
Noel-Storr, Anna H. |
|
2013 |
9 |
3 |
p. e96-e105 nvt p. |
artikel |